Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarke Neumann Insider Profile
4 Followers
Clarke Neumann, VP & GC at Sequenom, holds 54.69K shares in Progenity (Ticker: PROG), holds 21.91K shares in Sequenom (Ticker: SQNM).
Clarke Neumann Sequenom (SQNM)VP & GC
Sequenom (SQNM)
VP & GC
Not Ranked
Clarke Neumann has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
General Counsel and Secretary
Roles that Clarke Neumann holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Clarke Neumann
Clarke Neumann's Trading History
Sequenom
Feb 08, 2012
―
Uninformative Buy
―
$52.36K
Progenity
Aug 18, 2020
General Counsel and Secretary
Uninformative Buy
―
$213.28K
List of latest transactions for each holding click on a transaction to see Clarke Neumann's performance on stock
You May Also Like
Clarke Neumann insider profile FAQ
What is the percentage of profitable transactions made by Clarke Neumann?
The percentage of profitable transactions made by Clarke Neumann is ―.
What is the average return per transaction made by Clarke Neumann?
The average return per transaction made by Clarke Neumann is ―.
What stocks does Clarke Neumann hold?
Clarke Neumann holds: SQNM, PROG stocks.
What was Clarke Neumann’s latest transaction?
Clarke Neumann latest transaction was an Uninformative Buy of ―.
What was Clarke Neumann's most profitable transaction?
Clarke Neumann’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Clarke Neumann's role in Sequenom?
Clarke Neumann's role in Sequenom is VP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.